Skip to main navigation Skip to search Skip to main content

Dose Ranging & Safety Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6<17 Years of Age

Project: Research

Project Details

StatusFinished
Effective start/end date09/15/0309/14/04

Funding

  • AstraZeneca LP: $14,750.00